Skip to content
Our Top 15 Most-Clicked Stories of 2022
Thanks for joining us in Year 1 of Bio.News. We published over 700 ...
Read More
Updated COVID boosters slash hospitalization risk by 50%
The Centers for Disease Control and Prevention (CDC) said updated COVID-19 booster vaccines ...
Read More
FDA approves first monoclonal antibody to treat COVID-19
The U.S. Food and Drug Administration (FDA) approved Genentech’s Actemra to treat COVID-19 ...
Read More
What’s happening with the COVID IP waiver expansion?
The United States and the Biotechnology Innovation Organization (BIO) have been taking action ...
Read More
Senate confirms Alexis Taylor as USDA trade undersecretary
The Senate on Wednesday confirmed Alexis Taylor to become the U.S. Department of ...
Read More
What’s in the government’s omnibus spending package
The text of the 4,155-page, $1.7 trillion omnibus spending bill was delivered around ...
Read More
EDITORS' CHOICE
Congressional commission urges support in U.S.-China competition for biotech dominance
Maintaining biotechnology superiority is essential to the U.S. economy and national security, and it must be supported with strategic federal funding that leans into America’s ...
Read More
LATEST NEWS
Federal Policy
Nkarta’s Hastings discusses environment for biotech funding in Endpoints panel
Speaking on a recent Endpoints News panel, Nkarta CEO Paul Hastings discussed the impact of regulatory uncertainty and federal funding cuts on the investment climate ...
Federal Policy
U.S. leadership in rare disease drugs at risk, BIO expert tells Orphan Drug Congress
America has long been the global leader in rare disease drug development but this leadership is at risk unless Congress protects key incentives In 1983, ...
Agriculture
BIO applauds reintroduction of two bills aimed at patent reform
The May 1 reintroduction of two bills designed to strengthen the certainty of U.S. patents earned praise from the Biotechnology Innovation Organization (BIO). The Patent ...
Federal Policy
BIO report outlines use of NAMs to reduce animal testing
Safeguarding human health during clinical research is critically important, but biotechnology has shown that this does not always have to mean using animals to test ...
Health
Q1 roundup of state health policy impacting biotech
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move into the mid-year, the Biotechnology ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
Q1 roundup of state health policy impacting biotech
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move ...
Read More
International
Bio's View
BIO campaign urges: ‘Invest in America. Vaccinate’
Now that vaccines have all but eliminated smallpox, measles, polio, and other childhood scourges in the U.S., it seems easy ...
Read More
